Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 19 - Drugs for skeletal disorders
Patents for A61P 19 - Drugs for skeletal disorders (81,981)
03/2000
03/29/2000CN1050840C 咪唑脂氧合酶抑制剂 Imidazole lipoxygenase inhibitors
03/29/2000CN1050760C Traditional Chinese medicine for treating soft tissue injury and dermatosis
03/28/2000US6043054 Polynucleotides encoding a novel GABA BP polypeptide
03/28/2000US6042610 Meniscal augmentation device
03/28/2000CA2245903A1 Use of pex in the treatment of metabolic bone diseases
03/23/2000WO2000015807A1 Method for down-regulating osteoprotegerin ligand activity
03/23/2000WO2000015797A2 Compositions and methods for the treatment of immune related diseases
03/23/2000WO2000015794A1 Human cell junction pdz protein
03/23/2000WO2000015793A2 Human gpcr proteins
03/23/2000WO2000015792A2 Promotion or inhibition of angiogenesis and cardiovascularization
03/23/2000WO2000015785A2 GENE MODIFICATION IN THE GENE FOR THE DIE Gβ3-SUB-UNIT OF HUMAN G-PROTEIN
03/23/2000WO2000015775A1 Rnase p polypeptides
03/23/2000WO2000015770A2 Human serine/threonine protein kinases
03/23/2000WO2000015614A1 Novel compounds
03/23/2000WO2000015611A1 Branched alkyl pyrrolidine-3-carboxylic acids
03/23/2000WO2000015273A1 Biologically active implants
03/23/2000WO2000015248A2 Growth factor-containing composition for healing tissue damage
03/23/2000WO2000015247A2 Methods of treating multiple myeloma and myeloma-induced bone resorption using integrin antagonists
03/23/2000WO2000015244A2 Pharmaceutical preparation containing a cyclopeptide and a chemotherapeutic agent or an angiogenesis inhibitor
03/23/2000WO2000015228A1 Combinations of tetracyclic cyclic gmp-specific phosphodiesterase inhibitors with further therapeutic agents
03/23/2000WO2000015214A1 Fc RECEPTOR MODULATORS AND USES THEREOF
03/23/2000WO2000015208A2 New use of immunosupressants for mmp-mediated diseases
03/23/2000WO2000015198A1 Orally administered controlled drug delivery system providing temporal and spatial control
03/23/2000WO2000000599A3 Composition for the induction of apoptosis in target cells
03/23/2000WO1999061418A3 1α-HYDROXY-25-ENE-VITAMIN D, ANALOGS AND USES THEREOF
03/23/2000DE19844291A1 New aminoalkylaminoalkyl-substituted benzoxazines or benzothiazines, are nitrogen monoxide synthase inhibitors useful for treating neurodegenerative, inflammatory, autoimmune or cardiovascular disease
03/23/2000DE19842415A1 Pharmaceutical preparation for treating e.g. tumors, thrombosis or inflammation, contains cyclic pentapeptide integrin inhibitor and chemotherapeutic agent and/or angiogenesis inhibitor
03/23/2000CA2344151A1 Pharmaceutical preparation
03/23/2000CA2343760A1 Orally administered controlled drug delivery system providing temporal and spatial control
03/23/2000CA2343654A1 Method for down-regulating osteoprotegerin ligand activity
03/23/2000CA2343578A1 Human serine/threonine protein kinases
03/23/2000CA2342833A1 Human gpcr proteins
03/23/2000CA2342301A1 Human cell junction pdz protein
03/23/2000CA2341440A1 Novel compounds
03/22/2000EP0987917A1 Method of cell data transmission, cell, communication system and corresponding network terminal unit
03/22/2000EP0987552A2 Diarylsulfonylurea binding proteins
03/22/2000EP0987032A1 Osteoinduction
03/22/2000EP0986574A1 11$g(b)-ARYL SUBSTITUTED 14,17-ETHANO-OESTRATRIENS, METHOD FOR THE PRODUCTION OF THESE COMPOUNDS AND THEIR USE IN THE PRODUCTION OF MEDICAMENTS.
03/22/2000EP0986530A1 Indane compounds and their pharmaceutical use
03/22/2000EP0986400A1 Integrin ligand, human mindin
03/22/2000EP0986395A1 Peptide parathyroid hormone analogs
03/22/2000CN1248262A 16-hydroxy-11-(substituted phenyl)-estra-4,9-diene derivatives
03/22/2000CN1247761A Rheumatism treating medicine
03/22/2000CN1247746A Osteomyelitis treating medicine and method
03/21/2000US6040329 Substituted indazole analogs
03/21/2000US6040321 Enzyme inhibitor treating cancer, inflammation and arthritis, neurodegenerative diseases such as alzheimer's disease, cardiovascular diseases, viral diseases and fungal diseases
03/21/2000US6040320 Antiinflammatory agent for treating diseases associated with overproduction of inflammatory cytokines, such as rheumatoid arthritis, inflammatory bowel disease, septic shock, osteoporosis, and osteoarthritis
03/21/2000US6040311 Treating bone disorders for preventing osteoporosis or inhibiting bone resorption in a mammal; treating tumor growth in a mammal
03/21/2000US6040306 Method of treating psoriasis, arthritis and reducing the toxicity of cancer chemotherapy
03/21/2000US6040133 D-enzyme compositions and methods of their use
03/16/2000WO2000014236A2 Grf analogs with increased biological potency
03/16/2000WO2000014235A1 Kunitz domain polypeptide zkun6
03/16/2000WO2000014230A1 Novel molecules of the herpes virus-entry-mediator-related protein family and uses thereof
03/16/2000WO2000014097A2 Novel pyranoses
03/16/2000WO2000014086A1 Chemokine receptor antagonists and methods of use therefor
03/16/2000WO2000014083A1 SUBSTITUTED η-PHENYL-Δ-LACTONES AND ANALOGS THEREOF AND USES RELATED THERETO
03/16/2000WO2000014073A1 Benzodiazepinone derivatives, preparation method and intermediates therefor, use as medicines and compositions
03/16/2000WO2000014066A1 4,4-biarylpiperidine derivatives with opioid receptor activity
03/16/2000WO2000013709A2 Methods of treating osteoarthritis with inducible nitric oxide synthase inhibitors
03/16/2000WO2000013706A1 Methods for detecting, preventing, and treating renal disorders by modulating, regulating, and inhibiting connective tissue growth factor
03/16/2000WO1999061471A3 Human transmembrane proteins
03/16/2000WO1999012561A9 FRACTURE HEALING USING PTHrP ANALOGS
03/16/2000DE19841698A1 Composition for accelerating healing of tissue damage in cartilage or wounds, comprises thrombocyte growth factor, fibrin or fibrinogen and polymer
03/16/2000CA2342882A1 Chemokine receptor antagonists and methods of use therefor
03/16/2000CA2342855A1 Novel pyranoses
03/16/2000CA2342349A1 Methods of treating osteoarthritis with inducible nitric oxide synthase inhibitors
03/16/2000CA2342280A1 Methods for detecting, preventing, and treating renal disorders by modulating, regulating, and inhibiting connective tissue growth factor
03/16/2000CA2342070A1 Grf analogs with increased biological potency
03/16/2000CA2340686A1 Novel molecules of the herpes virus-entry-mediator-related protein family and uses thereof
03/15/2000EP0985149A1 Methods for evaluating tissue morphogenesis and activity
03/15/2000EP0984981A1 Anti-inflammatory tyrosine derivatives
03/15/2000EP0984963A1 Novel compounds
03/15/2000EP0984959A1 Aromatic sulfonyl alpha-hydroxy hydroxamic acid compounds
03/15/2000EP0984955A1 SUBSTITUTED 2-(2,6-DIOXOPIPERIDIN-3-YL)-PHTHALIMIDES AND 1-OXOISOINDOLINES AND METHOD OF REDUCING TNF$g(a) LEVELS
03/15/2000EP0567566B1 Methods for treating tumor necrosis factor mediated diseases
03/15/2000CN1247568A Fibroblast growth factor homologs
03/15/2000CN1247541A Steroids substituted in position 11, method of prepn. application as medicines and pharmaceutical compsns. containing them
03/15/2000CN1247531A Arylsulfonyl hydroxamic acid derivatives
03/15/2000CN1247191A Imidazolium compound as synthetic material of imidazole lipoxidase inhibitor
03/15/2000CN1247074A Medical capsules for treating arthritides and its preparing process
03/15/2000CA2282075A1 Osteoinduction
03/14/2000US6037373 Treating nervous system, cytological, hormonal, gastrointestinal and liver disorders
03/14/2000CA2009542C Cyclic guanidines as calcium antagonists
03/14/2000CA2008263C Pyrazolopyridine compound and processes for preparation thereof
03/09/2000WO2000012720A2 Elongase genes and uses thereof
03/09/2000WO2000012689A1 Polypeptides and polynucleotides from coagulase-negative staphylococci
03/09/2000WO2000012682A1 Primate embryonic stem cells with compatible histocompatibility genes
03/09/2000WO2000012551A1 HUMAN LATENT TRANSFORMING GROWTH FACTOR-β BINDING PROTEIN 3
03/09/2000WO2000012517A1 Novel hydrate forms of alendronate sodium, processes for manufacture thereof, and pharmaceutical compositions thereof
03/09/2000WO2000012514A1 Novel compounds
03/09/2000WO2000012498A1 Quinolin-2-one derivatives useful as anticancer agents
03/09/2000WO2000012497A2 Quinazoline derivatives as medicaments
03/09/2000WO2000012485A1 Pyrimidine compounds
03/09/2000WO2000012478A1 Arylpiperazines and their use as metalloproteinase inhibiting agents (mmp)
03/09/2000WO2000012477A1 Hydroxamic acid derivatives as proteinase inhibitors
03/09/2000WO2000012467A1 N-hydroxyacylamino compounds, process for their preparation and pharmaceutical compositions containing them
03/09/2000WO2000012106A1 Gabab1aa receptor
03/09/2000WO2000012084A1 Geometrically restricted 2-indolinone derivatives as modulators of protein kinase activity
03/09/2000WO2000012083A1 Formamides as therapeutic agents
03/09/2000WO2000012074A2 Use of piperidines and/or piperazines as inhibitors of p38-alpha kinase
1 ... 750 751 752 753 754 755 756 757 758 759 760 761 762 763 764 765 766 767 768 769 770 ... 820